Claim Missing Document
Check
Articles

Found 2 Documents
Search

Diagnosis and treatment of leprous neuropathy: a review Thiodorus, Fira; Thiodorus, Robert; Sadeli, Marrietta Sugiarti
Bali Dermatology Venereology and Aesthetic Journal BDVAJ - Volume 7, Issue 1 (January 2024)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/balidervenaesthj.v7i1.78

Abstract

One significant subset of curable neuropathies brought on by Mycobacterium leprae is leprous neuropathy. Millions of people in most underdeveloped nations suffer from leprous neuropathy, which can lead to debilitating motor deficiencies, sensory loss, and skin deterioration. The peripheral nerve system and skin are the primary organs affected by leprosy. The clinical characteristics, cutaneous histology, and bacteriology may all be used to conclude the diagnosis. Leprosy neuropathy diagnosis also requires a nerve biopsy. Needles electromyography and nerve conduction investigations are two examples of electrophysiologic nerve examinations. Both studies offer details on the degree of nerve involvement, the location of lesions, and the underlying mechanism of injury. For patients with leprosy neuropathy, multiple medication therapies are recommended. Aside from standard medical care, acute neuropathy may sometimes require surgical intervention. In reversal reactions, corticosteroids can prevent or lessen nerve damage.
Pencegahan Disabilitas pada Kusta Thiodorus, Robert; Rusyati, Luh Made Mas; Sadeli, Marrietta Sugiarti
Jurnal Biomedika dan Kesehatan Vol 6 No 2 (2023)
Publisher : Fakultas Kedokteran Universitas Trisakti

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18051/JBiomedKes.2023.v6.216-223

Abstract

Leprosy, a chronic granulomatous infectious disease caused by Mycobacterium Leprae, presents a complex challenge with profound social, physical, and economic implications. The burden of leprosy is a persistent concern in many developing countries, despite substantial control efforts. The World Health Organization (WHO) initiated the "Global Leprosy Strategy 2016-2020" to combat this issue, focusing on reducing children diagnosed with leprosy, eliminating visible deformities, and enacting anti-discrimination laws. Disability in leprosy is multifaceted and preventing disability in leprosy is a critical endeavor, such as prophylaxis, early diagnosis, and comprehensive care strategies. Vaccination with the BCG vaccine provides moderate protection, and combining it with single-dose rifampicin (SDR) can enhance its effectiveness, particularly for lepromatous cases with delayed diagnoses. Improved training for healthcare providers can facilitate early detection, reducing the risk of disability. After effective leprosy treatment, longterm morbidity remains a concern. Continued education of healthcare workers and communities is pivotal in preventing damage to hands, feet, and eyes, especially in cases of peripheral neuropathy. Disability progression is a substantial risk, highlighting the need for ongoing medical assessments, even post-MDT treatment. Restructuring primary care services to ensure quality post-treatment care is essential. Stigma remains a significant obstacle in leprosy prevention. Community awareness and stigma reduction can motivate individuals to seek treatment. Epidemiological patterns transmission within households, play a crucial role in identifying new cases. Routine examinations of household contacts of leprosy patients can expedite early diagnosis. Nutrition also plays a role in leprosy prevention. Ensuring access to nutritious food is critical to reducing the risk of developing the disease. In conclusion, the prevention of disability in leprosy is a multifaceted endeavor that demands comprehensive strategies, early intervention, awareness, and community engagement. Addressing this issue is vital for improving the quality of life for individuals affected by leprosy and for achieving a leprosy-free world.